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Abstract. – OBJECTIVE: The aim of the pres-
ent study was to assess the association among 
anxiety, depression, stress, social support and 
emotional abilities with adherence and health-
care spending in type 2 diabetic patients. 
PATIENTS AND METHODS: Sixty-four pa-
tients were enrolled and completed: Interper-
sonal Processes of Care (IPC), 20-item Toronto 
Alexithymia Scale (TAS-20), Rapid Stress As-
sessment Scale (RSAS), Morisky Medication Ad-
herence Scale (MMAS-4), International Physical 
Activity Questionnaire (IPAQ)-Short Form and a 
socio-anamnestic questionnaire regarding also 
the healthcare spending. 
RESULTS: Mathematical linear regressions 
models were performed showing the predictive 
effects of: anxiety and social support scores 
(RSAS) on adherence levels (respectively p =. 
019; p =. 016); adherence levels on anxiolytic use 
(p =.04); aggressiveness scores (RSAS) on the 
number of general check-ups (p =.031); TAS-20 
and physician-patient communication (IPC) on 
the number of hospitalization days (respectively 
p=.001; p=.008); physician patient decision mak-
ing (IPC) scores on physical activity (IPAQ) lev-
els (p=.025); physical activity (IPAQ) on the num-
ber of medical examinations (p=.039).
CONCLUSIONS: An association among psy-
chosocial impairment, adherence and health-
care spending was found. Future studies should 
investigate the effect of a brief psychological in-
tervention in increasing adherence levels and 
reducing the healthcare spending in this clinical 
population.
Key Words:
Type-2 diabetes, Adherence, Psychological impair-
ment, Social support, Healthcare spending.
Introduction
Diabetes mellitus is a growing epidemic whose 
prevalence has increased also in those countries 
that have adopted western lifestyle pattern1. In 
Italy more than three million people have diabetes 
and the 90% of them is affected by Type 2 Dia-
betes with substantial direct and indirect costs2. 
Direct costs are particularly related to long hospi-
talization due to acute and chronic complications 
and represent about the 60% of the total health 
expenditure associated to diabetes. Indirect costs 
are primarily related to the decrease or loss of pa-
tients’ social productivity3. The economic impact 
could be explained by a poor adherence to treat-
ment of diabetic patients. Adherence to treatment 
with oral hypoglycemic agents and accuracy in 
performing insulin therapy ranges respectively 
from 36% to 93% and from 20% to 80%; adhe-
rence to dietary recommendations is approxima-
tely the 65%, while less than 30% of the patients 
practices the recommended amount of physical 
exercise3. Previous studies3,4 found an association 
between adherence to treatment and the healthca-
re costs related to diabetes, showing that a poor 
adherence was significantly correlated to higher 
healthcare utilization and costs. As regards the 
role of psychosocial dimensions on adherence, 
previous studies showed that higher difficulty 
in identifying and describing emotions was ne-
gatively correlated to poorer glycemic control5,6. 
Psychological factors, such as depression and 
anxiety, could also affect the adherence to treat-
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ment in diabetic patients. Previous studies showed 
that the depression rate in patients with diabetes 
was twice compared to general population7. Fur-
thermore, depression was negatively associated 
with self-care, glycemic control, quality of life, 
health outcomes and adherence to treatment regi-
men, so contributing to the higher healthcare uti-
lization and related costs8,9. Stressful experiences 
could also affect diabetes management10. Some 
studies11,12 highlighted the importance of social 
support in the management of diabetes, showing 
that social networks and family behaviours affect 
self-managements capabilities and adherence to 
treatment. Similarly, the interpersonal processes 
between physicians and patients may influence 
patient outcomes including adherence to treat-
ment recommendations13. In a recent systematic 
review was found that the one of the principal 
barriers related to the use of healthcare services 
were physician characteristics such as communi-
cation barriers, physician’s manners, and lack of 
competence of physicians14. The aim of the pre-
sent study was to assess the association among 
psychological, social and emotional variables wi-
th adherence levels and healthcare spending. The 
main hypothesis was that psychological, social 
and emotional impairments may be negatively 
associated with adherence and healthcare spen-
ding. Furthermore, a second hypothesis was that 
a lower level of adherence may predict a higher 
healthcare spending.
Patients and Methods
Procedure
Following local Ethical Committee approval, 
sixty-four type 2 diabetic patients were enrolled in 
the study. The research was carried out in colla-
boration with the medical staff of the Diabetology 
Department of the Policlinico Umberto I, Rome, 
Italy. Patients were consecutively enrolled between 
July 2015 and February 2016. The inclusion crite-
ria were: age between 55 and 90 years, diagnosis 
of type 2 diabetes since at least one year, level of 
education no lower than primary school, Italian or 
foreign citizenship with knowledge of Italian lan-
guage, and absence of psychopathology. All par-
ticipants signed an informed consent. Anonymity 
was guaranteed by assigning a numerical code to 
each subject and the sensitive material was held in 
custody only by the researchers of the study. Each 
patient was asked to participate in the study during 
the day hospital visit with clinician at the Diabe-
tology Department. The patients who accepted to 
participate were asked to have an interview in a 
quiet room with a psychologist in order to fill the 
questionnaires and to collect the data.
Measures
The administered self-report questionnaires 
were the following: 
a) The Interpersonal Processes of Care (IPC) 
is a patient-reported instrument, assessing 
patient-physician interpersonal processes of 
care. The survey evaluates several sub-do-
mains of communication, patient-centered 
decision making, and interpersonal style. It 
contains 29 items and the score is calculated 
on 4-point Likert scale ranging from 1 to 5. 
The reliability coefficient of the instrument 
ranges from 0.64 to 0.9315. 
b) 20-item Toronto Alexithymia Scale - 20 
(TAS- 20) is a self-report instrument used to 
assess alexithymic levels, it contains 20 item 
which respond through a 5-point Likert scale 
(ranging from strongly disagree to strongly 
agree. The test specifically measures three 
distinct factors of alexithymia: difficulty in 
identifying feelings (DIF-F1), difficulty in 
describing feelings (DDF-F2), and external-
ly oriented thinking (EOT-F3). The current 
version of the TAS-20 showed a high internal 
consistency (Cronbach’s alpha = 0.81)16. 
c) The Rapid Stress Assessment Scale (RSAS) 
explores individual responses to stressful 
situations dividing the individual responses 
into five dimensions (clusters): depression, 
anxiety, somatization, aggressiveness and 
social support. It consists of 15 items: 9 of 
these are referred to the state of the person at 
the time of questionnaire completion, and the 
other 6 measure longitudinal variables rela-
ted to the last six months. The RSAS was va-
lidated in an Italian sample showing a test-re-
test Pearson correlation coefficient between 
r=.70 and r=.92 (p<.0001)17.
d) The Morisky Medication Adherence Scale 
(MMAS-4) is a self-report questionnaire, 
medication-taking behaviour scale, validated 
for hypertension but used also in diabetic pa-
tients [18]. The original version of the scale 
(MMAS-4) consists of four items with a sco-
ring scheme of “Yes” = 0 and “No” = 1. The 
score of each item is summed to obtain a total 
scores ranging from low adherence to high 
adherence. The test showed a Chronbach’s 
alpha of .5519. 
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e) The International Physical Activity Que-
stionnaire (IPAQ) - Short Form, investigates 
three specific types of activity: walking, mo-
derate-intensity activities and vigorous inten-
sity activities; frequency (measured in days 
per week) and duration (time per day) are 
collected separately for each specific type of 
activity. The Cronbach’s alpha on items about 
physical activity in the short version is 0.6020. 
f) The socio-demographic questionnaire was 
designed to collect information concerning 
participants’ age, gender, diagnosis of type 2 
diabetes since at least one year, level of edu-
cation no lower than primary school. This 
questionnaire also includes 5 questions rela-
ted to health care spending aimed to investi-
gate the costs associated with diabetes over 
the last year such as frequency of general 
check-up, number of medical examinations, 
hospitalization days and use of antidepres-
sants and anxiolytics.
Statistical Analysis
The number of patients included in the study 
was based on previous results and a priori power 
analysis using G*Power 3.1.5. (Kiel, Germany). 
The sample size calculation was performed on the 
basis of the primary endpoint (correlation betwe-
en adherence and depression). It was estimated 
that a minimum of 50 patients (total sample n) 
would be required to detect correlation between 
adherence and psychological characteristics (Rho 
= -0.35) with a power of 80% assuming α=.05.
Correlation analyses (Pearson r) were con-
ducted on the hypothesised associations. Linear 
regressions were performed in order to assess 
predictive factors for adherence to treatment and 
healthcare spending among those significant on 
the correlation analysis (p<.05). The analyses we-
re performed using STATISTICA 9.0 (Tulsa, OK, 
USA). 
Results
No patients were excluded from the study and 
the data of sixty-four type 2 diabetic patients (me-
an age 67 ± 11 years, 44 males and 20 females) 
were analyzed. 
Correlation analyses revealed that anxiety 
(-.26; p=.035) and social support scores (RSAS) 
(.27; p=.028) were significantly related to Morisky 
Medication Adherence scores; TAS-20 difficulty 
in identifying feelings (-.26; p=.038), difficulty in 
describing feelings (-.25; p=.045) and IPC physi-
cian-patient decision-making scores (.32; p=.011) 
were significantly related to physical activity sco-
res (IPAQ). 
Mathematical linear regressions models con-
firmed the predictive effect of anxiety (p=.019) 
and social support (RSAS) (p=.016) on Morisky 
Medication Adherence scores (R=39 R²=.15 
Adjusted R²=.13; F(2,61)=5.6; p<.006); while 
only physician-patient decision making (IPC) 
(p=0.025) showed a predictive effect on physi-
cal activity questionnaire scores (R=.42 R²=.18 
Adjusted R²=.14; F(3,60)=4.4; p<.007 (Table I). 
Also adherence variables were correlated with 
healthcare spending variables. More specifically, 
Morisky Medication Adherence was significantly 
correlated to anxiolytics use (-.26; p=.040); phys-
ical activity scores were significantly correlated 
to the number of medical examinations (-.26; 
p=.039). Mathematical linear regressions mod-
els showed a predictive effect of Morisky Medi-
cation Adherence scores (p=0.04) on anxiolytic 
use (R=.26 R²=.07 Adjusted R²=.05; F(1,62)=4.4; 
p<.040), and also the predictive effect of physi-
Table I. Results of multiple linear regression predicting Morisky Medication Adherence Scale and International Physical 
Activity Questionnaire. 
Morisky Medication Adherence: R=.39 R²=.15 Adjusted R²=.13; F (2,61)=5.6 p<.006. 
 b* S.E. b S.E. t p
Anxiety (RSAS) -0.28 0.12 -0.11 0.05 -2.40 .019
Social support (RSAS) 0.29 0.12 0.13 0.05 2.48 .016
International Physical Activity Questionnaire: R=.42 R²=.18 Adjusted R²=.14; F(3,60)=4.4 p<.007.
 b* S.E. b S.E. t p
Difficulty Identifying Feelings (TAS-20)  0.01 0.18 6.89 169.49 0.04 .968
Difficulty Describing Feelings (TAS-20) 0.04 0.17 53.32 224.40 0.24 .813
Physician patient decision making (IPC) 0.29 0.12 397.11 171.90 2.31 .025
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cal activity scores (IPAQ) (0.039) on the number 
of medical examinations (R=.26 R²=.07 Adjusted 
R²=.05; F(1,62)=4.4; p<.04). 
Finally, psychological, emotional, and social va-
riables were also correlated with healthcare spen-
ding variables. Anxiety (.31; p=.013), depression 
(.38; p=.002) and aggressiveness scores (RSAS) 
(.32; p=.011) were related to the number of general 
check-up. TAS-20 total and externally oriented thin-
king were positively correlated with the number of 
hospitalization days (.41; p=.001 and .31; p=.011, re-
spectively) while Physician-patient communication 
(IPC) showed a negative correlation to the number 
of hospitalization days (-.35; p=.015). Mathemati-
cal linear regressions models highlighted that only 
aggressiveness (RSAS) showed a predictive effect 
on the number of general check-up, and that TAS-
20 total score and physician-patient communication 
(IPC) showed a predictive effect on the number of 
hospitalization days (Table II). 
Discussion
The main finding of the present study was that 
a greater emotional, social, and psychological im-
pairment was associated to a lower adherence to 
the treatment in patients with type-2 diabetes. Mo-
reover, the lower adherence to the treatment was 
associated with a higher healthcare spending. Fi-
nally, greater emotional and social impairments 
were associated with a greater healthcare spending. 
Specifically, higher level of anxiety, lower level of 
perceived social support and higher difficulty in 
describing emotions predicted a lower adherence 
to treatment. These findings confirmed the results 
of previous studies which highlighted that emo-
tional impairment, higher scores of anxiety and 
lower levels of perceived social support predicted 
poor adherence to the treatment in diabetic pa-
tients as well as in other chronic diseases6,21,22. It 
was interesting that higher perception of decision 
making shared with the physician was associated 
with a greater physical activity. In diabetic patient, 
practicing physical activities, as well as following 
a specific diet regimen, could have a relevant in-
fluence on glycemic control and on the prevention 
of possible complications22. This finding confirms 
the result of a previous study highlighting the im-
pact of a positive relationship between patient and 
physician on treatment adherence in diabetic pa-
tients23. Sharing the decision-making process with 
the physician and establishing a good relationship 
with him represents an element that can help the 
processes of care and the adherence to physician’ 
recommendations. In the present study, lower le-
vels of adherence to treatment predicted higher 
healthcare costs regarding hospitalization duration 
(days) and use of anxiolytics. These findings con-
firm previous studies highlighting that lower levels 
of adherence to the treatment were associated wi-
th greater healthcare costs3. It is conceivable that 
less adherent diabetic patients are more prone to 
develop acute and chronic complications that lead 
to longer hospitalization. Moreover, the compli-
cations can influence patient’s anxiety favoring 
the use of anxiolytics. Another result of the study 
showed that lower physical activity predicted gre-
ater recourse to medical examinations. It is con-
ceivable that inactive patients are more prone to 
develop acute and chronic complications and, con-
sequently, they ask for higher number of medical 
examinations. In the present study it can also be 
note the significant associations between psycholo-
gical variables and healthcare spending: higher le-
vels of aggressiveness and somatization predicted 
higher number of general check-ups. In previous 
studies somatization was associated with increased 
use of hospital services24,25. These findings highli-
ght the link between psychological variables and 
Table II. Results of multiple linear regression predicting healthcare spending variables. 
General check-up: R=.45 R²=.21 Adjusted R²=.17; F (3,60)=5.2 p<.003. 
 b* S.E. b S.E. t p
Anxiety (RSAS) -0.20 0.20 -0.02 0.02 -1.01 .316
Depression (RSAS) 0.31 0.18 0.03 0.02 1.69 .097
Aggressiveness (RSAS) 0.36 0.16 0.03 0.01 2.21 .031
Hospitalization days: R=.51 R²=.26 Adjusted R²=.23; F (2,61)=10.6 p<.000.
 b* S.E. b S.E. t p
TAS-20 total 0.37 0.11 0.21 0.06 3.34 .001
Physician patient communication (IPC) -0.31 0.11 -0.23 0.08 -2.76 .008
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pressive symptoms prior to and following insulin 
initiation in patients with type 2 diabetes mellitus: 
prevalence, risk factors and effect on physician 
resource utilisation. Prim Care Diabetes 2015; 9: 
346-353.
10) Gonzalez js, shreCk e, Psaros C, saFren sa. Distress 
and type 2 diabetes-treatment adherence: A me-
diating role for perceived control. Health Pychol 
2015; 34: 505-513.
11) koetsenruijter j, Van eikelenBoom n, Van lieshout j, 
VassileV i, lionis C, toDoroVa e, Portillo mC, Foss 
C, serrano Gil m, roukoVa P, anGelaki a, mujika a, 
knutsen ir, roGers a, wensinG m. Social support 
and self-management capabilities in diabetes 
patients: an international observational study. Pa-
tient Educ Couns 2016; 99: 638-643. 
12) mayBerry ls, osBorn Cy. Family support, medi-
cation adherence, and glycemic control among 
adults with type 2 diabetes. Diabetes Care 2012; 
35: 1239-1245.
13) Piette jD, sChillinGer D, Potter mB, heisler m. Di-
mension of patient- provider communication and 
diabetes self-care in an ethnically diverse popula-
tion. J Gen Int Med 2003; 18: 624-633. 
14) PaDuCh a, kuske s, sChiereCk t, Droste s, loerBroks 
a, sørensen m, maGGini m, iCks a, Joint Action on 
Chronic Diseases and Promoting Healthy Ageing 
across the Life Cycle (JA-CHRODIS). Psychoso-
healthcare costs, suggesting that somatization may 
increase the use of healthcare service because of 
the subjectively perceived symptoms. Moreover, 
aggressiveness seems to have an influence on dia-
betes care causing greater distress, as shown in a 
previous study26. Furthermore, greater emotional 
impairment (high alexithymia total scores) was 
predictive of a substantial increase in hospitaliza-
tion days. This finding is consistent with previous 
studies where higher level of alexithymia was asso-
ciated with poorer glycaemic control in diabetic pa-
tients6 and with poorer adherence to the treatment 
in renal transplanted patients27,28. The difficulty in 
identifying and describing feelings may have a ne-
gative effect on self-care behaviors, contributing to 
poor glycemic control or poor adherence to medi-
cal prescriptions. Interestingly, physician-patient 
communication quality was negatively correlated 
with the number of hospitalization days. This fin-
ding confirms previous studies where the involve-
ment of the patients in treatment decisions and a 
positive physician-patient communication was able 
to predict a shorter duration of hospitalization3. 
The present study has an important limitation: the 
values of adherence and healthcare spending were 
collected using self-report questionnaire. It would 
have been helpful in answering the research que-
stion to having access both to biological markers 
associated to adherence and spending indicators 
from national health archives. In a future study it 
should be planned. 
Conclusions
We showed an association between psycholo-
gical dimensions, adherence and healthcare spen-
ding relevant for physicians and clinicians who 
work in this field. As new question arising from 
these findings, the importance to investigate the 
effectiveness of psychological intervention in in-
creasing the adherence to treatment and psycho-
social wellbeing and in reducing the healthcare 
costs in diabetic patients emerged.
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